GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qualigen Therapeutics Inc (FRA:7R90) » Definitions » Payments to Suppliers for Goods and Services

Qualigen Therapeutics (FRA:7R90) Payments to Suppliers for Goods and Services


View and export this data going back to 2020. Start your Free Trial

What is Qualigen Therapeutics Payments to Suppliers for Goods and Services?

Payments to Suppliers for Goods and Services only applicable to companies reporting Cash Flow from Operations in direct method.


Qualigen Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qualigen Therapeutics Inc (FRA:7R90) » Definitions » Payments to Suppliers for Goods and Services
Traded in Other Exchanges
Address
5857 Owens Avenue, Suite 300, Carlsbad, CA, USA, 92008
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.